Stay updated on Ziftomenib in AML Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib in AML Clinical Trial page.

Latest updates to the Ziftomenib in AML Clinical Trial page
- Check3 days agoChange DetectedThe website footer revision changed from v3.7.2 to v3.8.0. The study record content remains unchanged.SummaryDifference0.0%

- Check10 days agoChange DetectedA notice was added explaining that NIH is transitioning from the term “artificial intelligence” to “super intelligence” and linking to updates and FAQs.SummaryDifference0.3%

- Check17 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check24 days agoChange DetectedThe site’s displayed revision changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page history now shows a new revision version (v3.7.0) replacing the previous v3.6.6, signaling an updated release of the page's revision metadata rather than any changes to the trial data or eligibility information.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page history now shows Revision: v3.6.6. This replaces the previous Revision: v3.6.5.SummaryDifference0.0%

Stay in the know with updates to Ziftomenib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib in AML Clinical Trial page.